个人简介
1998.09～2001.07北京协和医学院 临床医学专业 学士
2002.09～2006.12 北京协和医学院 肿瘤分子药理学 博士
2006.12～2007.03中国医学科学院药物研究所 助理研究员
2007.04～2009.02 美国Van Andel 研究所 博士后
2009.04～2013.08 中国医学科学院药物研究所 助理研究员
2013.09至今 中国医学科学院药物研究所 副研究员
研究领域
主要从事抗肿瘤药物的分子药理学研究及新药创制与开发。
近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1. Yan Li, Wanqi Zhou, Xiaoguang Chen. The effect of Aurora kinases on cell proliferation, cell cycle regulation and metastasis in renal cell carcinoma . Int J Oncol. 2012; 41(6):2139-49 (2.657)
2. Yan Li，Ke Tang, Haijing Zhang, Yi Zhang, Wanqi Zhou, Xiaoguang Chen. Function of Aurora kinase A in Taxol-resistant breast cancer and its correlation with P-gp. Mol Med Report. 2011; 4 (4 ): 739-46 (0.418)
3. Sen Zhang, Yan Li, Xiaoguang Chen et al. Renal‑protective effect of nicousamide on hypertensive nephropathy in spontaneously hypertensive rats. Biomedical Reports.2013; 1: 34-40（co-first author）.
4. Yan Li, Zhong-Fa Zhang, Jindong Chen， Bin Tean The et al. VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. Am J Transl Res 2010;2(3):296-308
5. 李燕，郝志勇，陈晓光. hPPARγ2单克隆抗体的制备与鉴定. 中国免疫学杂志. 2010;26(6):533-537.
6. 李燕，辛洪启，左明新，陈晓光. hPPARγ2高表达细胞模型的建立及与细胞恶性程度的关系. 中国新药杂志. 2010; 19(9):785-792.
7. 李燕，张文明，陈晓光. PPAR γ激动剂诱导HT-29凋亡及周期阻滞的作用. 哈尔滨商业大学学报（自然科学版）. 2009;25(3): 257-263.
8. 李燕，刘悦，陈晓光. PPAR γ激动剂罗格列酮对HT-29的生长抑制作用. 哈尔滨商业大学学报（自然科学版）. 2009;25(4):385-398.
9. 秦爱方, 李燕, 宋宏锐, 陈晓光, 金小锋, 王克, 张莉婧, 霍连超, 冯志强. 含吡啶-2-酰肼结构的索拉非尼类似物的设计、合成及其抗肿瘤活性 药学学报 2012, 47(12) 1623-1629（共同第一作者）.
10. Zhang S, Li Y, Li H, Zheng X, Chen X. Renal-protective effect of nicousamide on hypertensive nephropathy in spontaneously hypertensive rats. Biomed Rep. 2013 Jan;1(1):34-40. Epub 2012 Sep 25.
11. Qing Zhou, Yan Li, Jing Jin, Liwei Lang, Zhixiang Zhu, Weishuo Fang, Xiaoguang Chen. Lx2-32c, a novel taxane derivative, exerts anti-resistance activity by initiating intrinsic apoptosis pathway in vitro and inhibits the growth of resistant tumor in vivo. Biol. Pharm. Bull. 2012, 35(12), 2170-2179
12. Xiangyan Li, Yan Li, Yi Zhang, Ke Wang, Xia Yuan, Jing Jin, Yan Zhang, Zhanzhu Liu, Xiaoguang Chen. (2011) A novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase C b pathway, in chronic myelogenous leukemia K562 cells. Leukemia & Lymphoma. 2011 Online on May 3
13. Jing Li, Yan Li, Zhiqiang Feng, Xiaoguang Chen. F84, a quinazoline derivative, exhibits high potent antitumor activity against human gynecologic malignancies. Investigational New Drugs, 2010, 28(2): 132
14. Jing Li, Yan Li, Zhi-qiang Feng, Xiao-guang Chen. Anti-tumor activity of a novel EGFR tyrosine kinase inhibitor against human NSCLC in vitro and in vivo. Cancer Letters. 2009,(279): 213–220.
15. 唐 克，李 燕，陈晓光多靶点抗肿瘤药物索拉菲尼的研究进展中国新药杂志. 2012, 20(24):2434-2441,
16. Jin J, Zhang Y, Li Y, Zhang H, Li H, Yuan X, Li X, Zhou W, Xu B, Zhang C, Zhang Z, Zhu L, Chen X. RNA-interference-mediated downregulation of Pin1 suppresses tumorigenicity of malignant melanoma A375 cells. Neoplasma. 2013, 60(1):92-100. doi: 10.4149/neo_2013_013.
17. Zhang S, Xin H, Li Y, Zhang D, Shi J, Yang J, Chen X.Skimmin, a coumarin from hydrangea paniculata, slows down the progression of membranous glomerulonephritis by anti-inflammatory effects and inhibiting immune complex deposion. Evid Based Complement Alternat Med. 2013;2013:819296. doi: 10.1155/2013/819296. Epub 2013 Aug 6.
18. Zhang S, Li H, Li Y, Zhang F, Liu Y, Chen X. Nicousmide normalizes renovascular pypertension in two-kidney one-clip hypertensive rats. Biomed Rep. 2013 Jan;1(1):89-92. Epub 2012 Oct 22.
19. Dan Huang, Yan ding, Yan Li, wang-Mei Luo, Zhong-Fa Zhang, John Snder, Kristin Vandenbeldt, Chao-Nan Qian, Bin Tean The. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma. Cancer Res. 2010, 70:1053-1062.
20. Zhouguang Hui, Maria Tretiakova, Zhongfa Zhang, Yan Li, Bin Tean Teh, Bin S Teh et al. radiosensitization by Inhibiting STAT1 in Renal Cell Carcinoma. International Journal of Radiation Oncology. 2009, 73(1): 288-295
京公网安备 11010802027423号